Academic/ScientificNeurology updates Neurology Update: Adjunctive cenobamate for uncontrolled focal epilepsy in adults: phase II trial results June 12, 2020 A double-blind, randomised, placebo-controlled phase II study of adjunctive cenobamate in adults with uncontrolled focal epilepsy showed high rates of total seizure-freedom over 12 weeks. Read full update here. Neurology Update: Adjunctive cenobamate for uncontrolled focal epilepsy in adults: phase II trial results was last modified: June 12th, 2020 by EditorShare this...FacebookTwitterLinkedin 0 comment previous post ERN-RND & EAN Joint Webinars on Neurorehabilitation next post EAN launches a Task Force on Gender and Diversity issues in Neurology You may also like New EAN Guideline on trigeminal neuralgia April 11, 2019 Rare Disease Day: Interview with Holm Graessner, Coordinator Rare Neurologic Diseases European Reference Network February 28, 2018 Neurology Update: Neurosonology July 15, 2019 Activities 2016-2017 of the EAN Scientific Panel Coma and chronic disorders of consciousness September 25, 2017 Breaking News: The role of piriform gyrus in epilepsy surgery April 11, 2019 Activities of the EAN Scientific Panel Autonomic Nervous Disorders 2016-2017 November 23, 2017 European Journal of Neurology: April issue online! April 1, 2019 EAN invites Resident and Research Members to a new guideline training program February 8, 2019 Interview with Teresinha Evangelista on the European Reference Networks – following the Meeting of the Rare Neurologic Diseases Task Force at EAN 2017 August 18, 2017 Launch of Joint Webinars with the European Reference Networks for Rare Neurological Diseases and Rare Neuromuscular Diseases November 1, 2019 Leave a Comment Cancel ReplyYou need to be logged in to comment. Please login to MyEAN on top.